BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11162576)

  • 1. Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site.
    Lin CS; Chow S; Lau A; Tu R; Lue TF
    Biochem Biophys Res Commun; 2001 Jan; 280(3):693-9. PubMed ID: 11162576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and regulation of human PDE5A gene promoter.
    Lin CS; Chow S; Lau A; Tu R; Lue TF
    Biochem Biophys Res Commun; 2001 Jan; 280(3):684-92. PubMed ID: 11162575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
    Lin CS; Chow S; Lau A; Tu R; Lue TF
    Int J Impot Res; 2002 Feb; 14(1):15-24. PubMed ID: 11896473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression, distribution, and regulation of PDE5.
    Lin CS
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S8-S10. PubMed ID: 15224128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three alternative first exons and an intronic promoter of human PDE5A gene.
    Lin CS; Lau A; Tu R; Lue TF
    Biochem Biophys Res Commun; 2000 Feb; 268(2):596-602. PubMed ID: 10679249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
    Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine monophosphate (cAMP) stimulation of the kit ligand promoter in sertoli cells requires an Sp1-binding region, a canonical TATA box, and a cAMP-induced factor binding to an immediately downstream GC-rich element.
    Grimaldi P; Capolunghi F; Geremia R; Rossi P
    Biol Reprod; 2003 Dec; 69(6):1979-88. PubMed ID: 12904318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.
    Kotera J; Fujishige K; Imai Y; Kawai E; Michibata H; Akatsuka H; Yanaka N; Omori K
    Eur J Biochem; 1999 Jun; 262(3):866-73. PubMed ID: 10411650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
    Salvi F; Sarzani R; Giorgi R; Donatelli G; Pietrucci F; Micheli A; Baldoni M; Minardi D; Dessì-Fulgheri P; Polito M; Muzzonigro G; Rappelli A
    Int J Impot Res; 2004 Oct; 16(5):412-7. PubMed ID: 15175637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the promoter region of the human RFP gene.
    Iwata Y; Nakayama A; Murakami H; Iida K; Iwashita T; Asai N; Takahashi M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):381-4. PubMed ID: 10425194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
    Lefièvre L; De Lamirande E; Gagnon C
    J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, distribution and regulation of phosphodiesterase 5.
    Lin CS; Lin G; Xin ZC; Lue TF
    Curr Pharm Des; 2006; 12(27):3439-57. PubMed ID: 17017938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum.
    Lin CS; Lau A; Tu R; Lue TF
    Biochem Biophys Res Commun; 2000 Feb; 268(2):628-35. PubMed ID: 10679255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of two isoforms of phosphodiesterase 5 from rat penis.
    Lin CS; Lin G; Lue TF
    Int J Impot Res; 2003 Apr; 15(2):129-36. PubMed ID: 12789393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
    Sopory S; Kaur T; Visweswariah SS
    Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.